DOCSLIB.ORG

Clopidogrel with Aspirin in High-Risk Patients with Acute Non-Disabling

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Clopidogrel with Aspirin in High-Risk Patients with Acute Non-Disabling Open access Protocol Stroke Vasc Neurol: first published as 10.1136/svn-2020-000791 on 5 May 2021. Downloaded from Clopidogrel with aspirin in High- risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial Yongjun Wang,1,2 Claiborne Johnston ,3 Philip M Bath,4 Xia Meng,1,2 Jing Jing,1,2 Xuewei Xie ,1,2 Anxin Wang ,1,2 Yuesong Pan ,1,2 Anding Xu ,5 Qiang Dong,6 Yilong Wang,1,2 Xingquan Zhao,1,2 Zixiao Li,1,2 Hao Li ,1,2 For the CHANCE-2 Investigators To cite: Wang Y, Johnston C, ABSTRACT High- risk patients with Acute Non- disabling Bath PM, et al. Clopidogrel Background In patients with a minor ischaemic stroke Cerebrovascular Events (CHANCE) trial and with aspirin in High-risk or transient ischaemic attack (TIA), separate trials have patients with Acute Non- the Platelet- Oriented Inhibition in New TIA shown that dual antiplatelet therapy with clopidogrel plus disabling Cerebrovascular and Minor Ischaemic Stroke (POINT) trial, a Events II (CHANCE-2): rationale aspirin (clopidogrel–aspirin) or ticagrelor plus aspirin lower risk of stroke recurrence was observed and design of a multicentre (ticagrelor–aspirin) are more effective than aspirin alone with a combination of clopidogrel and aspirin in stroke secondary prevention. However, these two sets randomised trial. Stroke & (clopidogrel–aspirin) than with aspirin Vascular Neurology 2021;0. of combination have not been directly compared. Since 3 4 doi:10.1136/svn-2020-000791 clopidogrel was less effective in stroke patients who were alone. However, the choice of an optimal CYP2C19 loss- of- function (LOF) allele carriers, whether dual antiplatelet therapy regimen for patients ► Additional online with strokes requires a tailored approach supplemental material is ticagrelor–aspirin is clinically superior to clopidogrel– published online only. To view, aspirin in this subgroup of patients with stroke is unclear. based on the characteristics of the patient. please visit the journal online Aim To describe the rationale and design considerations The genetic substudy of the CHANCE trial (http:// dx. doi. org/ 10. 1136/ svn- of the Clopidogrel in High- risk patients with Acute Non- showed that clopidogrel plus aspirin reduced 2020- 000791). disabling Cerebrovascular Events (CHANCE-2) trial. the risk of stroke recurrence in non- carriers http://svn.bmj.com/ Design CHANCE-2 is a randomised, double- blind, double- Received 9 December 2020 of the cytochrome P450 2C19 (CYP2C19) dummy, placebo- controlled, multicentre trial that compares Revised 15 March 2021 loss-of- function (LOF) alleles compared Accepted 9 April 2021 two dual antiplatelet strategies for minor stroke or TIA with aspirin alone but not in carriers. There- patients who are CYP2C19 LOF allele carriers: ticagrelor fore, clopidogrel may not provide additional (180 mg loading dose on day 1 followed by 90 mg twice benefit in stroke prevention compared with daily on days 2–90) or clopidogrel (300 mg loading dose on 5 day 1 followed by 75 mg daily on days 2–90), plus open- aspirin alone for the carriers. More recently, on September 28, 2021 by guest. Protected copyright. label aspirin with a dose of 75–300 mg on day 1 followed the substudy of POINT failed to reproduce by 75 mg daily on day 2–21. All will be followed for 1 year. the above findings as seen in the CHANCE 6 Study outcomes The primary efficacy outcome is any trial, possibly from a limited statistical power. stroke (ischaemic or haemorrhagic) within 3 months and In addition, a meta- analysis of 15 studies that the primary safety outcome is any severe or moderate included 4762 patients with stroke or TIA bleeding event within 3 months. found that carriers of CYP2C19 LOF alleles Discussion The CHANCE-2 trial will evaluate whether were at higher risk of vascular events than ticagrelor–aspirin is superior to clopidogrel–aspirin for non- carriers when taking clopidogrel.7 minor stroke or TIA patients who are CYP2C19 LOF allele Ticagrelor is a reversible oral antago- carriers. © Author(s) (or their nist directly blocking the P2Y12- adenosine Trial registration number NCT04078737. employer(s)) 2021. Re-use diphosphate receptor that needs no catab- permitted under CC BY-NC. No commercial re- use. See rights olite activation, which in turn yields greater and permissions. Published by INTRODUCTION AND RATIONALE mean levels of platelet inhibition than clopi- BMJ. In patients with acute non-disabling cerebro- dogrel.8 9 From the Acute Stroke or Tran- For numbered affiliations see vascular events, including those with acute sient Ischaemic Attack Treated with Aspirin end of article. minor stroke or transient ischaemic attack or Ticagrelor and Patient Outcomes trial (TIA), the subsequent recurrent stroke and involving participants with acute ischaemic Correspondence to Dr Yongjun Wang; cardiovascular events are more than 6% in stroke or TIA, ticagrelor was not found to 1 2 yongjunwang@ ncrcnd. org. cn the first year. As shown in Clopidogrel in be more effective than aspirin in reducing Wang Y, et al. Stroke & Vascular Neurology 2021;0. doi:10.1136/svn-2020-000791 1 Open access Stroke Vasc Neurol: first published as 10.1136/svn-2020-000791 on 5 May 2021. Downloaded from the risk of 90- day vascular events.5 However, among Genotyping the Asian patients, a tendency towards better efficacy In this study, a novel point- of- care genetic test platform was seen in a subgroup analysis.10 The Platelet Reac- will be used to identify carriers of CYP2C19 LOF alleles tivity in Acute Stroke or Transient Ischaemic Attack including poor metabolisers with at least two *2 or *3 trial showed that participants with ischaemic stroke or alleles (*2/*2, *2/*3, or *3/*3) or intermediate metab- TIA who were treated with ticagrelor plus aspirin (tica- olisers with one *2 or *3 allele (*1/*2 or *1/*3). The grelor–aspirin) had a lower proportion of high platelet CYP2C19 genotyping will be implemented by the GMEX reactivity than those who were treated with clopidogrel– Point- of-Care Genotyping system, including a portable aspirin, particularly in the those who were CYP2C19 LOF DNA analyser, genotyping reagents, and a buccal sample allele carriers.11 The Acute Stroke or Transient Isch- collection kit. The system uses non- invasive sampling aemic Attack Treated with Ticagrelor and Aspirin for by buccal swab and integrates automated steps of DNA Prevention of Stroke and Death trial showed that dual extraction, PCR- based amplification, fluorescent signal antiplatelet therapy (ticagrelor–aspirin) was better than detection and genotype determination. The system inte- mono antiplatelet therapy (aspirin) for secondary stroke grates controls to monitor the performance of a run prevention in people with mild- to-moderate acute isch- and ensure ongoing quality from the GMEX system. aemic stroke or TIA, but the rate of haemorrhage was The analysis includes the single nucleotide polymor- also elevated.12 phisms CYP2C19*2 (681G>A, rs4244285), CYP2C19*3 While separate trials have shown similar treatment (636G>A, rs4986893), and CYP2C19*17 (−806C>T, effects, no direct comparison has been conducted in this rs12248560), which will be genotyped on screening. patient population. In some populations, more than 50% The average result turn- around- time for the method of 13 of them carry CYP2C19 LOF alleles so that the conver- GMEX is 85 min. sion to an active form of clopidogrel is reduced. We hence hypothesised that, compared with clopidogrel– Randomisation aspirin, ticagrelor–aspirin may favourably impact the Participants will be randomised (1:1) to receive either clinical outcomes in high-risk participants with acute non- ticagrelor–aspirin or clopidogrel–aspirin. A randomisa- disabling cerebrovascular events and were carriers of the tion sequence will be generated centrally using random- CYP2C19 LOF allele. Therefore, the CHANCE-2 trial was permuted fixed-size blocks methods from the Statistics designed to test such hypothesis. The intention of this trial and Data Centre at the China National Clinical Research is to evaluate the safety and efficacy of ticagrelor–aspirin Centre for Neurological Diseases. The randomisation versus clopidogrel–aspirin for minor stroke or high- risk computer program makes the treatment assignment TIA patients who were CYP2C19 LOF allele carriers. This based on the current status of treatment group distribu- article describes the design of the CHANCE-2 trial and is tion within each clinical centre as well as overall balance a summary of protocol. of treatment assignment. Following randomised alloca- http://svn.bmj.com/ tion, the study intervention will be administered to the patient as early as possible. METHODS Design and patients population Intervention CHANCE-2 is a randomised, double-blind, double- Eligible participants are randomly assigned to one of two dummy, placebo- controlled multicentre trial. Patients arms: on September 28, 2021 by guest. Protected copyright. with CYP2C19 LOF alleles are randomised with 1:1 to one of the two strategies (ticagrelor–aspirin or clopi- Ticagrelor–aspirin group dogrel–aspirin) within 24 hours of the onset of cere- A 180 mg loading dose of Ticagrelor on day 1, followed brovascular Events. All participants will be followed by 90 mg two times per day on days 2–90 plus a 75–300 for 3 months on study intervention, with another 9 mg loading dose of aspirin, followed by 75 mg daily for months of follow- up on standard of care. The study 21 days; design of the CHANCE-2 is shown in figure 1. The trial will enrol subjects age ≥40 years with acute non- Clopidogrel–aspirin group disabling ischaemic stroke, with a National Institutes A 300 mg loading dose of clopidogrel on day 1, followed of Health Stroke Scale (NIHSS) score ≤3 or high- risk by 75 two times per day on days 2–90 plus a 75–300 mg TIAs (ABCD2 score ≥4).
Load more

Recommended publications
  • Stress Hyperglycemia and Prognosis of Minor Ischemic Stroke And
    Stress Hyperglycemia and Prognosis of Minor Ischemic Stroke and Transient Ischemic Attack The CHANCE Study (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events) Yuesong Pan, MD*; Xueli Cai, MD*; Jing Jing, MD, PhD; Xia Meng, MD, PhD; Hao Li, PhD; Yongjun Wang, MD; Xingquan Zhao, MD, PhD; Liping Liu, MD, PhD; David Wang, DO; S. Claiborne Johnston, MD, PhD; Tiemin Wei, MD; Yilong Wang, MD, PhD; on behalf of the CHANCE Investigators Background and Purpose—We aimed to determine the association between stress hyperglycemia and risk of new stroke in patients with a minor ischemic stroke or transient ischemic attack. Downloaded from Methods—A subgroup of 3026 consecutive patients from 73 prespecified sites of the CHANCE trial (Clopidogrel in High- Risk Patients With Acute Nondisabling Cerebrovascular Events) were analyzed. Stress hyperglycemia was measured by glucose/glycated albumin (GA) ratio. Glucose/GA ratio was calculated by fasting plasma glucose divided by GA and categorized into 4 even groups according to the quartiles. The primary outcome was a new stroke (ischemic or hemorrhagic) at 90 days. We assessed the association between glucose/GA ratio and risk of stroke by multivariable Cox http://stroke.ahajournals.org/ regression models adjusted for potential covariates. Results—Among 3026 patients included, a total of 299 (9.9%) new stroke occurred at 3 months. Compared with patients with the lowest quartile, patients with the highest quartile of glucose/GA ratio was associated with an increased risk of stroke at 3 months after adjusted for potential covariates (12.0% versus 9.2%; adjusted hazard ratio, 1.46; 95% confidence interval, 1.06–2.01).
    [Show full text]
  • Confidential: for Review Only
    BMJ Confidential: For Review Only Ticagrelor with Aspirin for Platelet Reactivity in Minor Stroke or Transient Ischemic Attack Patients: A Randomized, Open-label, Blinded-endpoint Trial Journal: BMJ Manuscript ID BMJ-2018-047607.R1 Article Type: Research BMJ Journal: BMJ Date Submitted by the 27-Feb-2019 Author: Complete List of Authors: WANG, YILONG; Tiantan Comprehensive Stroke Center, Tiantan Hospital, Capital Medical University, Beijing, China, Chen, Weiqi; Beijing Tiantan Hospital, Capital Medical University Lin, Yi; Department of Neurology and Institute of Neurology, First Affiliated Hospital, Fujian Medical University Meng, Xia; Beijing Tiantan Hospital Capital Medical University, Department of Neurology Chen, Guohua; Department of Neurology, Wuhan No.1 Hospital Wang, zhimin; Department of Neurology, Taizhou First People's Hospital, Huangyan Hospital of Wenzhou Medical University Wu, Jialing; Department of Neurology, Tianjin Huanhu Hospital Wang, Dali; Department of Neurology, North China University of Science and Technology Affiliated Hospital, Li, Jianhua; Department of Neurology, the First Hospital of Fangshan District Cao, Yibin; Department of Neurology, Tangshan Gongren Hospital Xu, Yu-ming ; The First Affiliated Hospital of Zhengzhou University, Department of Neurology Zhang, Guohua; Department of Neurology, the Second Hospital of Hebei Medical University, Li, Xiaobo; Department of Neurology, Northern Jiangsu People's Hospital, Clinical Medical School, Yangzhou University PAN, YUESONG; Beijing Tiantan Hospital, Capital Medical
    [Show full text]
  • Martial Arts Cinema and Hong Kong Modernity
    Martial Arts Cinema and Hong Kong Modernity Aesthetics, Representation, Circulation Man-Fung Yip Hong Kong University Press Th e University of Hong Kong Pokfulam Road Hong Kong www.hkupress.org © 2017 Hong Kong University Press ISBN 978-988-8390-71-7 (Hardback) All rights reserved. No portion of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any infor- mation storage or retrieval system, without prior permission in writing from the publisher. An earlier version of Chapter 2 “In the Realm of the Senses” was published as “In the Realm of the Senses: Sensory Realism, Speed, and Hong Kong Martial Arts Cinema,” Cinema Journal 53 (4): 76–97. Copyright © 2014 by the University of Texas Press. All rights reserved. British Library Cataloguing-in-Publication Data A catalogue record for this book is available from the British Library. 10 9 8 7 6 5 4 3 2 1 Printed and bound by Paramount Printing Co., Ltd. in Hong Kong, China Contents Acknowledgments viii Notes on Transliteration x Introduction: Martial Arts Cinema and Hong Kong Modernity 1 1. Body Semiotics 24 2. In the Realm of the Senses 56 3. Myth and Masculinity 85 4. Th e Diffi culty of Diff erence 115 5. Marginal Cinema, Minor Transnationalism 145 Epilogue 186 Filmography 197 Bibliography 203 Index 215 Introduction Martial Arts Cinema and Hong Kong Modernity Made at a time when confi dence was dwindling in Hong Kong due to a battered economy and in the aft ermath of the SARS epidemic outbreak,1 Kung Fu Hustle (Gongfu, 2004), the highly acclaimed action comedy by Stephen Chow, can be seen as an attempt to revitalize the positive energy and tenacious resolve—what is commonly referred to as the “Hong Kong spirit” (Xianggang jingshen)—that has allegedly pro- pelled the city’s amazing socioeconomic growth.
    [Show full text]
  • Association Between CYP2C19 Loss-Of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients with Mi
    Research Original Investigation Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack Yilong Wang, MD, PhD; Xingquan Zhao, MD, PhD; Jinxi Lin, MD, PhD; Hao Li, PhD; S. Claiborne Johnston, MD, PhD; Yi Lin, MD, PhD; Yuesong Pan, MD; Liping Liu, MD, PhD; David Wang, DO, FAHA, FAAN; Chunxue Wang, MD, PhD; Xia Meng, MD, PhD; Jianfeng Xu, MD, PhD; Yongjun Wang, MD; for the CHANCE investigators Supplemental content at IMPORTANCE Data are limited regarding the association between CYP2C19 genetic variants jama.com and clinical outcomes of patients with minor stroke or transient ischemic attack treated with clopidogrel. OBJECTIVE To estimate the association between CYP2C19 genetic variants and clinical outcomes of clopidogrel-treated patients with minor stroke or transient ischemic attack. DESIGN, SETTING, AND PARTICIPANTS Three CYP2C19 major alleles (*2, *3, *17) were genotyped among 2933 Chinese patients from 73 sites who were enrolled in the Clopidogrel in High-Risk Patients with Acute Nondisabling Cerebrovascular Events (CHANCE) randomized trial conducted from January 2, 2010, to March 20, 2012. INTERVENTIONS Patients with acute minor ischemic stroke or transient ischemic attack in the trial were randomized to treatment with clopidogrel combined with aspirin or to aspirin alone. MAIN OUTCOMES AND MEASURES The primary efficacy outcome was new stroke. The secondary efficacy outcome was a composite of new composite vascular events (ischemic stroke, hemorrhagic stroke, myocardial infarction, or vascular death). Bleeding was the safety outcome. RESULTS Among 2933 patients, 1948 (66.4%) were men, with a mean age of 62.4 years.
    [Show full text]
  • Proceedings of the Second Workshop on Computational Approaches to Code Switching, Pages 1–11, Austin, TX, November 1, 2016
    EMNLP 2016 Second Workshop on Computational Approaches to Code Switching Proceedings of the Workshop November 1, 2016 Austin, Texas, USA c 2016 The Association for Computational Linguistics Order copies of this and other ACL proceedings from: Curran Associates 57 Morehouse Lane Red Hook, New York 12571 USA Tel: +1-845-758-0400 Fax: +1-845-758-2633 [email protected] ISBN 978-1-945626-28-9 ii Introduction Code-switching (CS) is the phenomenon by which multilingual speakers switch back and forth between their common languages in written or spoken communication. CS is pervasive in informal text communications such as news groups, tweets, blogs, and other social media of multilingual communities. Such genres are increasingly being studied as rich sources of social, commercial and political information. Apart from the informal genre challenge associated with such data within a single language processing scenario, the CS phenomenon adds another significant layer of complexity to the processing of the data. Efficiently and robustly processing CS data presents a new frontier for our NLP algorithms on all levels. The goal of this workshop is to bring together researchers interested in exploring these new frontiers, discussing state of the art research in CS, and identifying the next steps in this fascinating research area. The workshop program includes exciting papers discussing new approaches for CS data and the development of linguistic resources needed to process and study CS. We received a total of 12 regular workshop submissions of which we accepted nine for publication four of them as workshop talks and five as posters. The accepted workshop submissions cover a wide variety of language combinations from languages such as English, Hindi, Swahili, Mandarin, Dialectical Arabic and Modern Standard Arabic.
    [Show full text]
  • UC San Diego UC San Diego Electronic Theses and Dissertations
    UC San Diego UC San Diego Electronic Theses and Dissertations Title Trans-media strategies of appropriation, narrativization, and visualization : adaptations of literature in a century of Chinese cinema Permalink https://escholarship.org/uc/item/5vd0s09p Author Qin, Liyan Publication Date 2007 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA, SAN DIEGO Trans-media Strategies of Appropriation, Narrativization, and Visualization: Adaptations of Literature in a Century of Chinese Cinema A Dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Literature by Liyan Qin Committee in charge Professor Yingjin Zhang, Chair Professor Michael Davidson Professor Jin-kyung Lee Professor Paul Pickowicz Professor Wai-lim Yip 2007 The Dissertation of Liyan Qin is approved, and it is acceptable in quality and form for publication on microfilm: Chair University of California, San Diego 2007 iii TABLE OF CONTENTS Signature Page………………………………………………………………………. …..iii Table of Contents……………………………………………………………………. …..iv Acknowledgements……………………………………………………………………...vii Vita……………………………………………………………………………………...viii Abstract……………………………………………………………………………...........ix Chapter 1 Introduction: The Concept of “Adaptation” and its Vicissitude in China……………………………………………………………………………………...1 Situating my Position in Current Scholarships………………………………….........3 The Intertwining of Chinese Film and Literature…………………………………...16 “Fidelity,”
    [Show full text]
  • Spatial Correlation of Particulate Matter Pollution and Death Rate of COVID-19
    medRxiv preprint doi: https://doi.org/10.1101/2020.04.07.20052142; this version posted April 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Spatial Correlation of Particulate Matter Pollution and Death Rate of COVID-19 Ye Yao †, Ph.D., Fudan University, Shanghai China † Jinhua Pan , M.Sc., Fudan University, Shanghai China Weidong Wang†, B.Med., Fudan University, Shanghai China Zhixi Liu†, B.Med., Fudan University, Shanghai China Haidong Kan, Ph.D. & M.D., Fudan University, Shanghai China Xia Meng*, Ph.D., Fudan University, Shanghai China Weibing Wang*, Ph.D. & M.D., Fudan University, Shanghai China †Dr. Yao, Ms. Pan, Mr. Wang and Ms. Liu contributed equally to this letter. * Corresponding authors: Dr. Weibing Wang, School of Public Health, Fudan University, Shanghai 200032, China, Email: [email protected] Dr. Xia Meng, School of Public Health, Fudan University, Shanghai 200032, China, Email: [email protected] Word account:1116 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.04.07.20052142; this version posted April 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license .
    [Show full text]
  • Beijing's Water Crisis: 1949-2008 Olympics
    Connecticut College Digital Commons @ Connecticut College Environmental Studies Honors Papers Environmental Studies Program 2013 Beijing’s Water Crisis: A Historical Analysis of Beijing’s Waterways using Geographic Information Systems Rebecca Tisherman Connecticut College, [email protected] Follow this and additional works at: http://digitalcommons.conncoll.edu/envirohp Part of the Water Resource Management Commons Recommended Citation Tisherman, Rebecca, "Beijing’s Water Crisis: A Historical Analysis of Beijing’s Waterways using Geographic Information Systems" (2013). Environmental Studies Honors Papers. 9. http://digitalcommons.conncoll.edu/envirohp/9 This Honors Paper is brought to you for free and open access by the Environmental Studies Program at Digital Commons @ Connecticut College. It has been accepted for inclusion in Environmental Studies Honors Papers by an authorized administrator of Digital Commons @ Connecticut College. For more information, please contact [email protected]. The views expressed in this paper are solely those of the author. Beijing’s Water Crisis: A Historical Analysis of Beijing’s Waterways using Geographic Information Systems by Rebecca Tisherman A Thesis Submitted in Fulfillment of the Requirements for Honors in a Degree of Bachelor of Arts in Environmental Studies Connecticut College May 2013 Thesis Committee: Thesis Advisor: Beverly Chomiak, Ph.D. Environmental Studies Program Department of Physics, Astronomy, and Geophysics Second Reader: Doug Thompson, Ph.D. Environmental Studies Program
    [Show full text]
  • SCIENTIFIC PROGRAM July 11 – 15, 2010, Jianguo Hotel Shanghai, China
    THE 8TH INTERNATIONAL SYMPOSIUM ON NEW MATERIALS AND NANO-MATERIALS FOR ELECTROCHEMICAL SYSTEMS SCIENTIFIC PROGRAM July 11 – 15, 2010, Jianguo Hotel Shanghai, China Sunday, July 11, 2010 9:30-20:00 Registration, F4 Grand Ball Room B (No other activities will occur during this day) Monday, July 12, 2010 7:30-18:00 Registration, F4 Grand Ball Room B 8:30-9:00 Welcome Remarks and Opening of the Symposium: Grand Ball Room A Chair: Zi-Feng Ma (Shanghai Jiao Tong University) 9:00-12:10 Plenary Symposium Talk: Grand Ball Room A Chair: O Savadogo, Ken-Ichiro Ota 9:00-9:45 [1] Prof. David P. Wilkinson (University of British Columbia, Vancouver, Canada) Clean energy and new materials / approaches for electrochemical systems 9:45-10:30 [2] Prof. Ken-Ichiro Ota (Yokohama National University, Japan) Development of non precious metal oxide cathode for PEMFC 10:30-10:40 Coffee Break 10:40-11:25 [3] Dr. Raghu N. Bhattacharya (US DOE’s National Renewable Energy Laboratory, USA) Thin Film Photovoltaic Technology 11:25-12:10 [4] Dr.Chendong Huang (New Energy Vehicle Division, SAIC Motor Corporation Limited, China) Demonstration of Fuel Cell Vehicle in 2010 Shanghai World EXPO 12:10-14:00 Lunch Time 1 Session 1: General Session Room: Plum Blossom Chair: O.Savadogo, Huamin Zhang 14:00-14:30 [8] Prof Huamin Zhang (Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China) Material Challenges to Redox Flow Battery for Energy Storage (Invited Speaker) 14:30-14:50 [9] A Sensor of Iron Based on A Porphyrin Functionalized Porous Silica, Roberto H.
    [Show full text]
  • Hours of Acute Minor Stroke Or Transient Ischemic Attack
    ORIGINAL RESEARCH Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack Zixiao Li, MD, PhD; Yilong Wang, MD, PhD; Xingquan Zhao, MD, PhD; Liping Liu, MD, PhD; David Wang, MD; Chunxue Wang, MD, PhD; Xia Meng, MD, PhD; Hao Li, PhD; Yuesong Pan, MD; Xianwei Wang, MD; Chunjuan Wang, MD, PhD; Xiaomeng Yang, MD; Changqing Zhang, MD, PhD; Jing Jing, MD, PhD; Ying Xian, MD, PhD; S. Claiborne Johnston, MD, PhD; Yongjun Wang, MD; on behalf of the CHANCE Investigators* Background-—The aim of this study was to analyze the benefits and safety associated with the combination therapy of clopidogrel and aspirin among minor stroke or transient ischemic attack patients treated within 12 hours. Methods and Results-—This was a subanalysis of the CHANCE (Clopidogrel in High-Risk Patients with Acute Nondisabling Cerebrovascular Events) trial, mainly limited to the prespecified group of patients randomized within 12 hours to either the combination of clopidogrel plus aspirin or aspirin alone. The primary outcome was ischemic stroke during 90-day follow-up. Recurrent ischemic stroke and progressive ischemic stroke were analyzed. Multivariable Cox modeling showed that randomization within 12 hours was an independent predictor of ischemic stroke events (hazard ratio [95% CI] 1.25 [1.04–1.49], P=0.02). Among 2573 patients randomized within 12 hours, 282 (10.96%) patients had ischemic stroke events. Among them, 158 (12.34%) of 1280 patients taking aspirin experienced ischemic stroke compared with 124 (9.59%) of 1293 patients taking clopidogrel–aspirin (P=0.02). The dual antiplatelet was more effective than aspirin alone in reducing the risk of recurrent ischemic stroke (6.57% versus 8.91%, P=0.03) but not progressive ischemic stroke (3.02% versus 3.43%, P=0.28).
    [Show full text]
  • The Efficacy and Safety of Nimodipine in Acute Ischemic Stroke Patients
    Science Bulletin 64 (2019) 101–107 Contents lists available at ScienceDirect Science Bulletin journal homepage: www.elsevier.com/locate/scib Article The efficacy and safety of nimodipine in acute ischemic stroke patients with mild cognitive impairment: a double-blind, randomized, placebo-controlled trial Huaguang Zheng a,1, Yilong Wang a,1, Anxin Wang a, Hao Li b, David Wang c, Xingquan Zhao a, Penglian Wang a, Haipeng Shen d, Lijun Zuo a, Yuesong Pan a, Zixiao Li a, Xia Meng a, Xianwei Wang a, Weixiong Shi a,YiJua, Liping Liu a, Kehui Dong a, Chunxue Wang a, Rubo Sui e, Rong Xue f, Xiaoping Pan g, ⇑ Xiaoyua Niu h, Benyan Luo i, Yi Sui j, Huali Wang k, Tao Feng a, Yongjun Wang a, , On behalf of the NICE trial group a Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China b China National Clinical Research Center for Neurological Diseases, Beijing 100022, China c OSF Saint Francis Medical Center Peoria, IL 61637-0001, USA d Faculty of Business and Economics, University of Hong Kong, China e The First Hospital, Liao Ning Medical College, Jinzhou 121001, China f The General Hospital, Tianjin Medical University, Tianjin 300070, China g Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou 510080, China h The First Hospital of Shanxi Medical University, Taiyuan 030001, China i The First Hospital, Zhejiang Medical University, Hangzhou 310006, China j Shenyang First People’s Hospital, Shenyang Medical College, Shenyang 110041, China k Dementia Care & Research Center, Peking University Institute of Mental Health, Beijing 100191, China article info abstract Article history: Nimodipine might be effective in subcortical vascular dementia (VaD).
    [Show full text]
  • Program Here
    The 7th International Forum for Surveillance and Control of Mosquitoes and Vector-borne Diseases (IFSCMVD) in Conjunction with the 13th Conference of Medical Entomology of the Entomological Society of China PROGRAM China, August 15-18, 2021 Sponsors： The Entomological Society of China State Key Laboratory of Pathogen and Biosecurity, China Organizers： Medical Entomology Committee, ESC Cooperation Asian Society of Vector Ecology and Mosquito Control Partners: The Society for Vector Ecology Insect Science Acta Parasitologica et Medica Entomologica Sinica The 7th International Forum for Surveillance and Control of Mosquitoes and Vector-borne Diseases (IFSCMVD) in Conjunction with the 13th Conference of Medical Entomology of the Entomological Society of China China, August 15-18, 2021 Meeting Theme: Challenges and Control Efforts for Mosquitoes and Vector-borne Diseases during Covid-19 Pandemic EXECUTIVE COMMITTEE Dr. Rui-De Xue, Conference President Dr. Tong-Yan Zhao, Program Chair Dr. Chun-Xiao Li, Secretary General Dr. Isik Unlu, President of the SOVE Dr. Abu Ahmad, President of the ASVEMC Dr. Qi-Yong Liu, Past President of the ASVEMC Conference Council: Abdul Althbyani Abu Hassan Ahmad Err-Lieh Hsu Gang Dong Graham B. White Gunter C. Muller Hoonbok Yi Huaiping Zhu Ildefonso Fernandez-Salas Jonas Schmidt-Chanasit K. Murugan Ken Linthicum Le Kang Major Dhillon Mustapha Debboun Paul Reiter Randy Gaugler Sekou F. Traore Theeraphap Charconviryyaphap Wu-Chun Cao Yan-Song Sun Program Committee: Dan Kline Feng-Lin Song Feng-Xia Meng Gong Cheng
    [Show full text]